Phase I/II study of mobocertinib in EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): Updated results from platinum-pretreated patients (PPP) Meeting Abstract
| Authors: | Ramalingam, S. S.; Zhou, C.; Kim, T. M.; Yang, J. C. H.; Riely, G. J.; Mekhail, T.; Nguyen, D.; Campelo, M. R. G.; Felip, E.; Misch, D.; Kaur, M.; Bunn, V.; Lin, M.; Zhang, P.; Jänne, P. A. |
| Abstract Title: | Phase I/II study of mobocertinib in EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): Updated results from platinum-pretreated patients (PPP) |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1004 |
| Language: | English |
| ACCESSION: | WOS:000866211601255 |
| DOI: | 10.1016/j.annonc.2022.07.1115 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 988P -- Source: Wos |
